Type 1 diabetes

Glycemia Risk Index Assessment in a Pediatric and Adult Patient Cohort With Type 1 Diabetes Mellitus

J Diabetes Sci TechnolPublished Cross-sectional study

Authors' conclusion

In pediatric patients and in those with CSII treatment, despite a better control by classical and GRI parameters, higher overall CHypo was observed than in adults and MDI, respectively. The present study supports the usefulness of the GRI as a new glucometric parameter to evaluate the global risk of hypoglycemia-hyperglycemia in both pediatric and adult patients with T1D.

Study context

Population
Patients with T1D on intensive insulin treatment (25.2% CSII) with isCGM, in clinical practice; 53% males, 67.8% adults, mean age 28.6 ± 15.7 years, 12.5 ± 10.9 years of T1D evolution
Participants
202 patients
Exposure
Pediatric vs adult patients; CSII vs multiple doses of insulin (MDI)
Outcome
Glycemia risk index (GRI), with its hypoglycemia (component of hypoglycemia (CHypo)) and hyperglycemia (component of hyperglycemia (CHyper)) components

Main finding

As reported in the abstract

GRI

Pediatric

48.0

± 22.2

Adults

56.8

± 23.4

CSII

51.0

± 15.3

MDI

55.0

± 25.4

Pediatric vs Adults: P < 0.05 · CSII vs MDI: P = 0.162

Observational data: associations, not effects.

Further findings

OutcomePediatricAdultsCSIIMDIP value
CHypoPediatric vs Adults7.1 ± 5.15.0 ± 4.56.5 ± 4.15.4 ± 5.0P < 0.01
CHypoCSII vs MDIP < 0.01
CHyperPediatric vs Adults16.8 ± 9.826.5 ± 15.119.6 ± 10.624.6 ± 15.2P < 0.01
CHyperCSII vs MDIP < 0.05
HbA1cAdults vs Pediatric · higher in adults6.7 ± 0.6 %7.4 ± 1.1 %— not stated in the abstract— not stated in the abstractP < 0.01
TIRAdults vs Pediatric · lower in adults66.5 ± 13.1 %55.4 ± 17.5 %— not stated in the abstract— not stated in the abstractP < 0.01
CVAdults vs Pediatric · lower in adults42.4 ± 8.9 %38.6 ± 7.2 %— not stated in the abstract— not stated in the abstractP < 0.05

— not stated in the abstract

Original publication

Glycemia Risk Index Assessment in a Pediatric and Adult Patient Cohort With Type 1 Diabetes Mellitus. J Diabetes Sci Technol. Published 16 February 2023. doi:10.1177/19322968231154561

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.